Evidence map›Paper›PMID 24367573›Full record

ArticlePloS one2013

FoxP3⁺ regulatory T cells attenuate experimental necrotizing enterocolitis.

Bridgette M Dingle, Yuying Liu, Nicole Y Fatheree, Juleen Min, J Marc Rhoads, Dat Q Tran

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 48 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Ontogeny of RORγtCell & bioscience · 2022
    Article
  16. Review
  17. Intestinal Regulatory T Cells.Advances in experimental medicine and biology · 2021
    Article
  18. The Association of Gut Microbiota and Treg Dysfunction in Autoimmune Diseases.Advances in experimental medicine and biology · 2021
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Bridgette M DingleDepartment of Pediatrics, The University of Texas Medical School, Houston, Texas, United States of America.
Yuying LiuDepartment of Pediatrics, The University of Texas Medical School, Houston, Texas, United States of America.
Nicole Y FathereeDepartment of Pediatrics, The University of Texas Medical School, Houston, Texas, United States of America.
Juleen MinDepartment of Pediatrics, The University of Texas Medical School, Houston, Texas, United States of America.
J Marc RhoadsDepartment of Pediatrics, The University of Texas Medical School, Houston, Texas, United States of America.
Dat Q TranDepartment of Pediatrics, The University of Texas Medical School, Houston, Texas, United States of America.
The University of Texas at Austin · US

Funding

Tissue Analysis & Molecular Imaging CoreP30DK056338 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI FASIHA KANWAL · 2001 to 2026
$28.3M
Stability and potency of LAP+FOXP3+Tregs as novel cell therapy for GVHDR01HL113304 · NHLBI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI TRAN, DAT QUOC · 2012 to 2016
$1.9M
NHLBI NIH HHS 1R01HL113304-01NHLBI NIH HHS R01 HL113304NIDDK NIH HHS P30 DK056338
6 · The paper itself

Abstract

Necrotizing enterocolitis (NEC) results from severe intestinal inflammation in premature infants. FoxP3(+) regulatory T cells (Tregs) are central to gut homeostasis. While Treg proportions are significantly reduced in the ileums of premature infants with NEC, it is unknown whether they play a critical function in preventing NEC. This study investigated Treg development in newborn rat pups and their role in experimental NEC induction. Utilizing an established rat model of experimental NEC, the ontogeny of T cells and Tregs in newborn pups was characterized by flow cytometry. To investigate the functions of Tregs, newborn pups were given Tregs harvested from adult rats prior to NEC induction to assess clinical improvement and mechanisms of immune regulation. The results revealed that there were few Treg numbers in the terminal ileums of newborn rats and 8-fold reduction after NEC. Adoptive transfer of Tregs significantly improved weight loss, survival from 53% to 88%, and NEC incidence from 87% to 35%. The Tregs modulated the immune response as manifested in reduced CD80 expression on antigen presenting cells and decreased T cell activation within the mesenteric lymph nodes. These findings suggest that while Tregs are present in the intestines, their numbers might be insufficient to dampen the excessive inflammatory state in NEC. Adoptive transfer of Tregs attenuates the severity of NEC by limiting the immune response. Strategies to enhance Tregs have a therapeutic potential in controlling the development of NEC.

Indexed as

AnimalsEnterocolitis, NecrotizingForkhead Transcription FactorsImmunotherapyRatsRats, Sprague-DawleyT-Lymphocytes, RegulatoryForkhead Transcription FactorsFoxp3 protein, rat

Identifiers

PMID24367573
PMCPMC3867412
OpenAlexW2043784391

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.